Inderal: Expert Beta-Blocker Therapy for Cardiovascular Control
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.51 | $46.21 (0%) | 🛒 Add to cart |
| 180 | $0.34 | $92.41 $61.27 (34%) | 🛒 Add to cart |
| 270 | $0.28 | $138.62 $75.34 (46%) | 🛒 Add to cart |
| 360 | $0.26
Best per pill | $184.82 $93.42 (49%) | 🛒 Add to cart |
| Product dosage: 40mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.56 | $50.22 (0%) | 🛒 Add to cart |
| 180 | $0.38 | $100.45 $68.30 (32%) | 🛒 Add to cart |
| 270 | $0.32 | $150.67 $86.39 (43%) | 🛒 Add to cart |
| 360 | $0.29
Best per pill | $200.90 $104.47 (48%) | 🛒 Add to cart |
| Product dosage: 80mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.74 | $44.20 (0%) | 🛒 Add to cart |
| 90 | $0.59 | $66.30 $53.24 (20%) | 🛒 Add to cart |
| 120 | $0.51 | $88.39 $61.27 (31%) | 🛒 Add to cart |
| 180 | $0.44 | $132.59 $79.35 (40%) | 🛒 Add to cart |
| 270 | $0.39 | $198.89 $105.47 (47%) | 🛒 Add to cart |
| 360 | $0.37
Best per pill | $265.18 $132.59 (50%) | 🛒 Add to cart |
Synonyms | |||
Similar products
Inderal (propranolol hydrochloride) is a non-selective beta-adrenergic blocking agent indicated for the management of hypertension, angina pectoris, cardiac arrhythmias, and other cardiovascular conditions. As a foundational therapy in cardiology and neurology, it functions by competitively blocking beta-adrenergic receptors, thereby reducing sympathetic nervous system activity. Its established efficacy, extensive clinical history, and versatile application profile make it a cornerstone in evidence-based therapeutic protocols for both acute and chronic conditions.
Features
- Active ingredient: Propranolol hydrochloride
- Available formulations: Immediate-release tablets (10 mg, 20 mg, 40 mg, 80 mg), extended-release capsules (60 mg, 80 mg, 120 mg, 160 mg), and injectable solution
- Pharmacologic class: Non-selective beta-blocker
- Half-life: Approximately 3–6 hours (immediate-release); 8–11 hours (extended-release)
- Bioavailability: ~25% (subject to significant first-pass metabolism)
- Protein binding: 90–95%
- Excretion: Primarily hepatic metabolism via CYP2D6 and CYP1A2; renal excretion of metabolites
Benefits
- Reduces myocardial oxygen demand by decreasing heart rate, contractility, and blood pressure, thereby alleviating angina symptoms
- Provides effective rhythm control in tachyarrhythmias by suppressing ectopic pacemaker activity and slowing AV nodal conduction
- Decreases both systolic and diastolic blood pressure through reduced cardiac output and inhibition of renin release
- Mitigates symptoms of sympathetic overactivation such as tremor and situational anxiety through peripheral beta-blockade
- Offers prophylactic benefit in migraine through uncertain mechanisms, possibly involving cerebral vasoconstriction
- May improve long-term cardiovascular outcomes in post-myocardial infarction patients by reducing reinfarction risk and mortality
Common use
Inderal is commonly prescribed for the management of hypertension, either as monotherapy or in combination with other antihypertensive agents. It is also widely used for rate control in atrial fibrillation and flutter, symptomatic relief in hypertrophic obstructive cardiomyopathy, and prophylaxis of migraine headaches. Off-label uses include essential tremor, situational anxiety (e.g., performance anxiety), and symptom management in hyperthyroidism. Its role in portal hypertension secondary to liver cirrhosis is also well-documented.
Dosage and direction
Dosage must be individualized based on clinical indication, patient response, and tolerability. For hypertension, initial dosing often begins at 40 mg twice daily (immediate-release), titrated upward as needed. For angina,起始剂量通常为80–320 mg daily in divided doses. Extended-release formulations are administered once daily. Administration with food may enhance bioavailability. Abrupt discontinuation should be avoided; tapering over 1–2 weeks is recommended to prevent rebound hypertension or angina exacerbation.
Precautions
Use with caution in patients with compensated heart failure, diabetes (may mask hypoglycemia symptoms), or hepatic impairment. Periodic monitoring of heart rate, blood pressure, and ECG is advised. May exacerbate bronchospasm in patients with reactive airway diseases. Can cause fatigue, dizziness, or bradycardia—caution when operating machinery. Not recommended during pregnancy unless potential benefit justifies potential risk (FDA Category C).
Contraindications
Inderal is contraindicated in patients with sinus bradycardia, heart block greater than first degree, cardiogenic shock, decompensated heart failure, and severe peripheral arterial circulatory disorders. It is also contraindicated in individuals with asthma or a history of bronchospasm due to non-selective beta-blockade. Hypersensitivity to propranolol or any component of the formulation prohibits use.
Possible side effect
Common adverse reactions include fatigue, bradycardia, nausea, diarrhea, and cold extremities. Less frequently, patients may experience sleep disturbances, depression, or vivid dreams. Serious side effects include exacerbation of heart failure, bronchospasm, severe bradycardia, and hypotension. Rare but severe reactions include hematologic abnormalities and hypersensitivity reactions.
Drug interaction
Inderal may interact with calcium channel blockers (additive bradycardia), antiarrhythmics (e.g., amiodarone), and insulin/oral hypoglycemics (potentiating hypoglycemia). Concomitant use with CYP2D6 inhibitors (e.g., fluoxetine) may increase propranolol levels. Avoid with epinephrine (unopposed alpha-effects may cause hypertension). Closely monitor when co-administered with digoxin or other negatively chronotropic agents.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next dose. Do not double the dose to make up for a missed one. Consistency in dosing is important to maintain stable plasma concentrations, particularly in extended-release formulations.
Overdose
Symptoms of overdose include severe bradycardia, hypotension, heart failure, bronchospasm, hypoglycemia, and seizures. Treatment is supportive and may include atropine for bradycardia, glucagon for myocardial stimulation, vasopressors for hypotension, and beta-agonists for bronchospasm. Hemodialysis is not effective due to high protein binding.
Storage
Store at controlled room temperature (20–25°C/68–77°F). Protect from light and moisture. Keep in original container and out of reach of children. Do not use beyond the expiration date printed on packaging.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personalized recommendations. Dosage and suitability depend on individual health status and concomitant conditions.
Reviews
Clinical studies and decades of use support the efficacy and safety of Inderal in appropriately selected patients. Many clinicians regard it as a reliable option for a spectrum of cardiovascular and neurologic indications. Patient experiences vary; some report significant symptomatic improvement, while others note side effects such as fatigue or cold intolerance. Adherence to prescribed dosing and regular follow-up are critical to therapeutic success.